Iovance Biotherapeutics, Inc. (IOVA) Free Cash Flow
Iovance Biotherapeutics, Inc. (IOVA) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$34.19M |
| 2017-12-31 | -$79.74M |
| 2018-12-31 | -$102.45M |
| 2019-12-31 | -$165.81M |
| 2020-12-31 | -$251.93M |
| 2021-12-31 | -$265.51M |
| 2022-12-31 | -$313.18M |
| 2023-12-31 | -$384.11M |
| 2024-12-31 | -$364.05M |
| 2025-12-31 | -$336.24M |
How IOVA compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| OCUL | Ocular Therapeutix Inc. | -$216.89M |
| EYPT | EyePoint Pharmaceuticals Inc. | -$243.39M |
| ARVN | Arvinas Inc. | -$275.70M |
| REPL | Replimune Group Inc. | -$284.57M |
| SNDX | Syndax Pharmaceuticals Inc. | -$323.17M |
These are five companies in the same sector as IOVA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Iovance Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("IOVA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IOVA | $8.19 | -1.27% | 9.75M |
| 3 | ||||
| 4 | ||||
| 5 |